JULINA LEWALLEN: Open Payments
NPI 1750987855 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 26 payments from 7 companies in 2025. Trend: 2023 $218 · 2024 $556 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $192 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Novo Nordisk Inc | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: LEQVIO, CREON, Wegovy, JARDIANCE, VRAYLAR, LINZESS, BOTOX, Kerendia.
Industry payments across CA — which companies pay providers there.
